Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,338 | 4 | 33.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,275 | 4 | 22.9% |
| Travel and Lodging | $2,183 | 4 | 22.0% |
| Food and Beverage | $1,948 | 37 | 19.6% |
| Education | $180.24 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genmab U.S., Inc. | $7,881 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $412.46 | 6 | $0 (2024) |
| Seagen Inc. | $256.30 | 3 | $0 (2023) |
| PFIZER INC. | $225.00 | 1 | $0 (2024) |
| Novocure Inc. | $157.47 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $145.93 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $143.96 | 3 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $139.29 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $134.21 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $112.88 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,147 | 23 | Genmab U.S., Inc. ($3,110) |
| 2023 | $5,284 | 24 | Genmab U.S., Inc. ($4,770) |
| 2022 | $235.16 | 2 | E.R. Squibb & Sons, L.L.C. ($119.32) |
| 2021 | $257.82 | 3 | AstraZeneca Pharmaceuticals LP ($97.85) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $109.25 | General |
| Category: ONC | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Oncology | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Oncology | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $23.10 | General |
| Category: Oncology | ||||||
| 07/15/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 05/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: ONCOLOGY | ||||||
| 05/07/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $123.46 | General |
| Category: Oncology | ||||||
| 05/03/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 05/01/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Travel and Lodging | In-kind items and services | $1,086.99 | General |
| Category: Oncology | ||||||
| 04/25/2024 | PFIZER INC. | TIVDAK (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $225.00 | General |
| Category: Oncology | ||||||
| 04/24/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Oncology | ||||||
| 04/18/2024 | E.R. Squibb & Sons, L.L.C. | AUGTYRO (Drug) | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| Category: Oncology | ||||||
| 04/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: ONCOLOGY | ||||||
| 02/16/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $139.29 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/04/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $134.37 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Hematology | ||||||
| 11/15/2023 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 131 | 374 | $117,290 | $34,066 |
| 2022 | 3 | 135 | 406 | $114,883 | $39,090 |
| 2021 | 3 | 143 | 424 | $112,940 | $39,251 |
| 2020 | 3 | 97 | 241 | $61,530 | $17,868 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 313 | $95,493 | $27,530 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 44 | $17,841 | $5,547 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 17 | $3,956 | $988.95 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 313 | $85,885 | $28,876 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 62 | $21,965 | $8,189 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 31 | $7,033 | $2,025 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 327 | $87,480 | $30,555 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 65 | $14,355 | $4,366 | 30.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 32 | $11,105 | $4,330 | 39.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 186 | $49,055 | $14,808 | 30.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 36 | $7,833 | $2,008 | 25.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 19 | $4,642 | $1,053 | 22.7% |
About Mae Dechristy
Mae Dechristy is a Family healthcare provider based in Sewell, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2018. The National Provider Identifier (NPI) number assigned to this provider is 1609374479.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mae Dechristy has received a total of $9,924 in payments from pharmaceutical and medical device companies, with $4,147 received in 2024. These payments were reported across 52 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($3,338).
As a Medicare-enrolled provider, Dechristy has provided services to 506 Medicare beneficiaries, totaling 1,445 services with total Medicare billing of $130,275. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Sewell, NJ
- Active Since 01/26/2018
- Last Updated 01/26/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1609374479
Products in Payments
- Tivdak (Drug) $7,881
- OPDIVO (Biological) $382.95
- TIVDAK (Biological) $375.00
- Optune (Device) $157.47
- KEYTRUDA (Biological) $143.96
- ZEPZELCA (Drug) $139.29
- Enhertu (Drug) $134.21
- Trodelvy (Drug) $109.25
- TAGRISSO (Drug) $97.85
- PADCEV (Biological) $94.97
- MYRISK (Device) $94.40
- LIBTAYO (Biological) $32.91
- LUMAKRAS (Drug) $31.80
- REBLOZYL (Biological) $31.78
- ENHERTU (Biological) $31.44
- Padcev (Drug) $29.73
- Xtandi (Drug) $18.15
- LYNPARZA (Drug) $16.64
- AUGTYRO (Drug) $15.44
- KRAZATI (Drug) $14.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sewell
Mrs. Sharon Winter-Scavicchio, Crnp, CRNP
Family — Payments: $5,396
Rafia Grooms, Dnp, DNP
Family — Payments: $2,471
Dawn Topper
Family — Payments: $1,094
Christy Heltzel, Crnp, CRNP
Family — Payments: $609.08
Courtney Mcanally, Crnp, CRNP
Family — Payments: $596.48
Jessica Ruiz, Fnp-Bc, Apn, FNP-BC, APN
Family — Payments: $484.15